Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will participate in the following investor conferences:
Wells Fargo 21st Annual Healthcare Conference (Boston) | Fireside Chat
September 8, 2026 (2:15 p.m. ET)
Citi's 2026 Biopharma Back to School Conference (New York) | Fireside Chat
